Director, Translational Science Lead
Leads translational science strategy for renal, inflammation, fibrosis, and neurodegeneration programs, driving biomarker development and validation from preclinical to clinical stages. Focuses on integrating multi-omics data, human assays, and novel technologies to inform clinical decision-making and patient stratification. Works across discovery and development to advance differentiated therapeutics through cross-functional collaboration and external partnerships.